These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
401 related items for PubMed ID: 25704026
1. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats. Kasahara K, Hashimoto S, Hattori T, Kawasaki K, Tsujita R, Nakazono O, Takao K, Kawakubo H, Nagatani T. J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026 [Abstract] [Full Text] [Related]
2. Anxiolytic effects of prelimbic 5-HT(1A) receptor activation in the hemiparkinsonian rat. Hui YP, Wang T, Han LN, Li LB, Sun YN, Liu J, Qiao HF, Zhang QJ. Behav Brain Res; 2015 Jan 15; 277():211-20. PubMed ID: 24906197 [Abstract] [Full Text] [Related]
3. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. Yamaguchi T, Tsujimatsu A, Kumamoto H, Izumi T, Ohmura Y, Yoshida T, Yoshioka M. J Ethnopharmacol; 2012 Sep 28; 143(2):533-9. PubMed ID: 22819689 [Abstract] [Full Text] [Related]
4. Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation. Saito Y, Matsumoto M, Yanagawa Y, Hiraide S, Inoue S, Kubo Y, Shimamura K, Togashi H. Synapse; 2013 Apr 28; 67(4):161-70. PubMed ID: 23152167 [Abstract] [Full Text] [Related]
5. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action. Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E. J Pharm Pharmacol; 2005 Feb 28; 57(2):253-7. PubMed ID: 15720791 [Abstract] [Full Text] [Related]
6. Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat. Muraki I, Inoue T, Koyama T. Eur J Pharmacol; 2008 May 31; 586(1-3):171-8. PubMed ID: 18423441 [Abstract] [Full Text] [Related]
7. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux. Huang M, Horiguchi M, Felix AR, Meltzer HY. Neuroreport; 2012 May 09; 23(7):436-40. PubMed ID: 22415605 [Abstract] [Full Text] [Related]
8. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent. Stachowicz K, Gołembiowska K, Sowa M, Nowak G, Chojnacka-Wójcik E, Pilc A. Neuropharmacology; 2007 Nov 09; 53(6):741-8. PubMed ID: 17870136 [Abstract] [Full Text] [Related]
9. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests. Jastrzębska-Więsek M, Siwek A, Partyka A, Kubacka M, Mogilski S, Wasik A, Kołaczkowski M, Wesołowska A. Neuropharmacology; 2014 Oct 09; 85():253-62. PubMed ID: 24905144 [Abstract] [Full Text] [Related]
10. [A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)]. Sasa M. Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr 09; 17(2):53-9. PubMed ID: 9201724 [Abstract] [Full Text] [Related]
11. Chronic treatment with tandospirone, a 5-HT(1A) receptor partial agonist, suppresses footshock stress-induced lactate production in the prefrontal cortex of rats. Uehara T, Matsuoka T, Itoh H, Sumiyoshi T. Pharmacol Biochem Behav; 2013 Nov 15; 113():1-6. PubMed ID: 24125783 [Abstract] [Full Text] [Related]
12. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease. Sun YN, Wang T, Wang Y, Han LN, Li LB, Zhang YM, Liu J. Neuropharmacology; 2015 Aug 15; 95():181-91. PubMed ID: 25797491 [Abstract] [Full Text] [Related]
14. Effect of transient blockade of N-methyl-D-aspartate receptors at neonatal stage on stress-induced lactate metabolism in the medial prefrontal cortex of adult rats: role of 5-HT1A receptor agonism. Uehara T, Itoh H, Matsuoka T, Rujescu D, Genius J, Seo T, Sumiyoshi T. Synapse; 2012 May 15; 66(5):408-17. PubMed ID: 22213269 [Abstract] [Full Text] [Related]
15. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats. Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E. J Pharm Pharmacol; 2003 Apr 15; 55(4):533-43. PubMed ID: 12803776 [Abstract] [Full Text] [Related]
16. [Effects of conditioned fear stress on monoaminergic systems in the rat brain]. Inoue T. Hokkaido Igaku Zasshi; 1993 May 15; 68(3):377-90. PubMed ID: 7686527 [Abstract] [Full Text] [Related]
17. Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test. Shimizu H, Tatsuno T, Tanaka H, Hirose A, Araki Y, Nakamura M. Jpn J Pharmacol; 1992 May 15; 59(1):105-12. PubMed ID: 1354771 [Abstract] [Full Text] [Related]
18. Serotonin 5-HT1A Receptor Biased Agonists Display Differential Anxiolytic Activity in a Rat Social Interaction Model. Depoortère R, Bardin L, Varney MA, Newman-Tancredi A. ACS Chem Neurosci; 2019 Jul 17; 10(7):3101-3107. PubMed ID: 30929419 [Abstract] [Full Text] [Related]
19. [Anxiolytic effects of serotonin reuptake inhibitors and their mechanism of action]. Hashimoto S. Hokkaido Igaku Zasshi; 2000 Nov 17; 75(6):421-36. PubMed ID: 11193934 [Abstract] [Full Text] [Related]
20. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior. Murata Y, Yanagihara Y, Mori M, Mine K, Enjoji M. J Affect Disord; 2015 Jul 15; 180():1-9. PubMed ID: 25879718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]